455 related articles for article (PubMed ID: 22914857)
1. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta.
Korkmaz S; Loganathan S; Mikles B; Radovits T; Barnucz E; Hirschberg K; Li S; Hegedüs P; Páli S; Weymann A; Karck M; Szabó G
J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):70-7. PubMed ID: 22914857
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent effects of a selective phosphodiesterase-5-inhibitor on endothelial dysfunction induced by peroxynitrite in rat aorta.
Korkmaz S; Radovits T; Barnucz E; Neugebauer P; Arif R; Hirschberg K; Loganathan S; Seidel B; Karck M; Szabó G
Eur J Pharmacol; 2009 Aug; 615(1-3):155-62. PubMed ID: 19482016
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
Korkmaz S; Radovits T; Barnucz E; Hirschberg K; Neugebauer P; Loganathan S; Veres G; Páli S; Seidel B; Zöllner S; Karck M; Szabó G
Circulation; 2009 Aug; 120(8):677-86. PubMed ID: 19667237
[TBL] [Abstract][Full Text] [Related]
4. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass.
Radovits T; Korkmaz S; Miesel-Gröschel C; Seidel B; Stasch JP; Merkely B; Karck M; Szabó G
Eur J Cardiothorac Surg; 2011 Feb; 39(2):248-55. PubMed ID: 20591683
[TBL] [Abstract][Full Text] [Related]
5. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
6. Effects of soluble guanylate cyclase activation on heart transplantation in a rat model.
Loganathan S; Korkmaz-Icöz S; Radovits T; Li S; Mikles B; Barnucz E; Hirschberg K; Karck M; Szabó G
J Heart Lung Transplant; 2015 Oct; 34(10):1346-53. PubMed ID: 26210750
[TBL] [Abstract][Full Text] [Related]
7. L-DOPA inhibits nitric oxide-dependent vasorelaxation via production of reactive oxygen species in rat aorta.
Yinhua ; Harada N; Mawatari K; Yasui S; Segawa H; Takahashi A; Oshita S; Nakaya Y
J Med Invest; 2009 Aug; 56(3-4):120-9. PubMed ID: 19763024
[TBL] [Abstract][Full Text] [Related]
8. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.
Stasch JP; Schmidt PM; Nedvetsky PI; Nedvetskaya TY; H S AK; Meurer S; Deile M; Taye A; Knorr A; Lapp H; Müller H; Turgay Y; Rothkegel C; Tersteegen A; Kemp-Harper B; Müller-Esterl W; Schmidt HH
J Clin Invest; 2006 Sep; 116(9):2552-61. PubMed ID: 16955146
[TBL] [Abstract][Full Text] [Related]
9. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
10. Irreversible Activation and Stabilization of Soluble Guanylate Cyclase by the Protoporphyrin IX Mimetic Cinaciguat.
Kollau A; Opelt M; Wölkart G; Gorren ACF; Russwurm M; Koesling D; Mayer B; Schrammel A
Mol Pharmacol; 2018 Feb; 93(2):73-78. PubMed ID: 29138269
[TBL] [Abstract][Full Text] [Related]
11. Effects of peroxynitrite on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
J Vasc Res; 2014; 51(6):439-46. PubMed ID: 25634663
[TBL] [Abstract][Full Text] [Related]
12. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
Chester M; Seedorf G; Tourneux P; Gien J; Tseng N; Grover T; Wright J; Stasch JP; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L755-64. PubMed ID: 21856817
[TBL] [Abstract][Full Text] [Related]
13. Role of soluble guanylate cyclase in renal hemodynamics and autoregulation in the rat.
Dautzenberg M; Kahnert A; Stasch JP; Just A
Am J Physiol Renal Physiol; 2014 Nov; 307(9):F1003-12. PubMed ID: 25209860
[TBL] [Abstract][Full Text] [Related]
14. Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats.
Hoffmann LS; Kretschmer A; Lawrenz B; Hocher B; Stasch JP
PLoS One; 2015; 10(12):e0145048. PubMed ID: 26717150
[TBL] [Abstract][Full Text] [Related]
15. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.
Chester M; Tourneux P; Seedorf G; Grover TR; Gien J; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2009 Aug; 297(2):L318-25. PubMed ID: 19465519
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of vasorelaxation induced by ethanol extract of Sophora flavescens in rat aorta.
Jin SN; Wen JF; Li X; Kang DG; Lee HS; Cho KW
J Ethnopharmacol; 2011 Sep; 137(1):547-52. PubMed ID: 21704693
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of vascular soluble guanylate cyclase induced by high salt intake in spontaneously hypertensive rats.
Kagota S; Tamashiro A; Yamaguchi Y; Sugiura R; Kuno T; Nakamura K; Kunitomo M
Br J Pharmacol; 2001 Oct; 134(4):737-44. PubMed ID: 11606313
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats.
Priviero FB; Zemse SM; Teixeira CE; Webb RC
Am J Hypertens; 2009 May; 22(5):493-9. PubMed ID: 19247264
[TBL] [Abstract][Full Text] [Related]
19. Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome.
Gladwin MT
J Clin Invest; 2006 Sep; 116(9):2330-2. PubMed ID: 16955136
[TBL] [Abstract][Full Text] [Related]
20. Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil.
Radovits T; Arif R; Bömicke T; Korkmaz S; Barnucz E; Karck M; Merkely B; Szabó G
Eur J Pharmacol; 2013 Jun; 710(1-3):110-9. PubMed ID: 23623933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
